Allergic rhinitis is a very common disorder that affects people of all ages, peaking in the
teenage years. It is frequently ignored, underdiagnosed, misdiagnosed, and mistreated …

Background Allergic rhinitis (AR) is increasingly acknowledged as having a substantial
socioeconomic impact associated with impaired work productivity, although available …

Abstract The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a
World Health Organization workshop in 1999. The initial goals were (1) to propose a new …

BACKGROUND: Moderate-to-severe allergic rhinitis (AR) is a challenge to treat, with many
patients using multiple therapies and achieving limited symptom control. More effective …

This report has been prepared by the European Academy of Allergy and Clinical
Immunology Task Force on Allergic Rhinitis (AR) comorbidities. The aim of this …

Allergic rhinitis (AR) is a serious systemic allergic disease, which together with comorbid
asthma causes major illness and disability worldwide. Recent epidemiological studies have …

Background Real‐world evidence is sparse on the benefits of allergen immunotherapy [AIT;
subcutaneous/sublingual immunotherapy (SCIT/SLIT)], the only disease‐modifying …

BACKGROUND: Allergies give rise to the fifth-leading group of chronic diseases. However,
the specific prevalence of ocular allergy is poorly described. OBJECTIVE: We sought to …

A significant proportion of rhinitis patients without systemic IgE‐sensitisation tested by skin
prick test and serum allergen‐specific IgE (sIgE) display nasal reactivity upon nasal allergen …

BACKGROUND: Sustained and disease-modifying effects of sublingual immunotherapy
have never before been confirmed in a large-scale randomized, double-blind, placebo …